Office of the Director, National Institutes of Health; Notice of Closed Meeting, 62640 [2013-24288]
Download as PDF
<![CDATA[
62640
Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Notices
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Branch, National Institute
on Aging, Gateway Bldg., 2c212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Research Centers.
Date: October 30–31, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bolger Center, 9600 Newbridge
Drive, Potomac, MD 20854.
Contact Person: William Cruce, Ph.D.,
Scientific Review Officer, National Institute
on Aging, Scientific Review Branch, Gateway
Building 2c212, 7201 Wisconsin Ave.,
Bethesda, MD 20814, 301–402–7704,
crucew@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Long Life
Family Studies.
Date: November 13, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Alicja L. Markowska,
Ph.D., DSC, Scientific Review Branch,
National Institute on Aging, 7201 Wisconsin
Avenue, Suite 2c212, Bethesda, MD 20892,
301–496–9666, markowsa@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–24290 Filed 10–21–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on DSK5SPTVN1PROD with FRONT MATTER
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Mar<15>2010
21:08 Oct 21, 2013
Jkt 232001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Bioinformatics,
Genetics and Genetic Epidemiology Grant
Applications.
Date: November 4, 2013.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Anne E. Schaffner, Ph.D.,
Chief, Scientific Review Branch, Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: September 30, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–24291 Filed 10–21–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel; Texas Biomed P51 SEP.
Date: November 7, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Sheri A. Hild, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Scientific Review, National
Center for Advancing Translational Sciences
(NCATS), National Institutes of Health, 6701
Democracy Blvd., Democracy 1, Room 1082,
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Bethesda, MD 20892–4874, 301–435–0811,
hildsa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 30, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–24288 Filed 10–21–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Drug Target Development
and Validation for Antimicrobial Resistant
Pathogens (R21/R33).
Date: October 31–November 1, 2013.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Silver Spring Hotel, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Susana Mendez, Ph.D.,
DVM, Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–496–2550,
mendezs@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Drug Target Development
and Validation for Antimicrobial Resistant
Pathogens (R21/R33).
Date: November 4–5, 2013.
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 78, Number 204 (Tuesday, October 22, 2013)]
[Notices]
[Page 62640]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24288]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Office of Research Infrastructure Programs
Special Emphasis Panel; Texas Biomed P51 SEP.
Date: November 7, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852, (Virtual Meeting).
Contact Person: Sheri A. Hild, Ph.D., Scientific Review Officer,
Office of Grants Management and Scientific Review, National Center
for Advancing Translational Sciences (NCATS), National Institutes of
Health, 6701 Democracy Blvd., Democracy 1, Room 1082, Bethesda, MD
20892-4874, 301-435-0811, hildsa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 30, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-24288 Filed 10-21-13; 8:45 am]
BILLING CODE 4140-01-P
